tirzepatide body soreness Muscle with Tirzepatide: Causes & Management Body Aches on Zepbound? Causes

Mounjaro launched in India in March 2025 and is approved for both type 2 diabetes and obesity

Sayed-Ahmad et al., 2022)

The FDA lists BPC-157 among bulk drug substances that may present significant safety risks in compounding, citing concerns such as immune reactions, peptide-related impurities, and limited safety information

Another meta-analysis of 15 RCTs found the greatest effect in hypertensive patients: SBP reduced by 6.8 mmHg and DBP by 4.6 mmHg [31]

At Reflections Medspa & Wellness Center in Lexington, KY, we understand these challenges and offer a specialized Weight Loss program designed to address these specific concerns